Beaconcure, a Boston, MA-based clinical data technology and automation company, raised $14M in Series B funding.
The round was led by NewVale Capital with participation from existing investors.
The company intends to use the funds to to expand its commercial organization, and to bring its platform to the market.
Led by CEO Yoran Bar, Beaconcure provides biopharmaceutical companies and CROs with an artificial intelligence, automated clinical trial data processing technology solution called ‘Verify’, which streamlines and automates the clinical trial data statistical analysis process. Developed in conjunction with its long-term partner Pfizer, and used in an increasing number of approved products, Verify shortens time to submission, reduces error-rates and costs over current processes and solutions. The platform is implemented by many of the top 10 pharmaceutical companies and Contract Research Organizations (CROs).
FinSMEs
14/06/2023